APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cystic Fibrosis (CF) Therapeutics

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Cystic Fibrosis (CF) Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025196 pages

Choose your research edition.

Industry ResearchCystic Fibrosis (CF) Therapeutics Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Cystic Fibrosis (CF) Therapeutics Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Cystic Fibrosis (CF) Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cystic Fibrosis (CF) Therapeutics Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Cystic Fibrosis (CF) Therapeutics Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Cystic Fibrosis (CF) Therapeutics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Cystic Fibrosis (CF) Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cystic Fibrosis (CF) Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cystic Fibrosis (CF) Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Cystic Fibrosis (CF) Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cystic Fibrosis (CF) Therapeutics include Teva Pharmaceutical Industries Ltd, Novartis AG, Merck & Co., Gilead, AbbVie,, AstraZeneca, Vertex Pharmaceuticalsorporated, F. Hoffmann-La Roche Ltd and ALLERGAN, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Cystic Fibrosis (CF) Therapeutics market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cystic Fibrosis (CF) Therapeutics and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cystic Fibrosis (CF) Therapeutics revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Cystic Fibrosis (CF) Therapeutics market size, projected growth trends, production technologies, key applications, and end-use industries.

Cystic Fibrosis (CF) Therapeutics Segment by Company

Teva Pharmaceutical Industries Ltd

Novartis AG

Merck & Co.

Gilead

AbbVie,

AstraZeneca

Vertex Pharmaceuticalsorporated

F. Hoffmann-La Roche Ltd

ALLERGAN

Alcresta

Alaxia

AIT (Advanced Inhalation Therapies)

Cystic Fibrosis (CF) Therapeutics Segment by Type

Bronchodilators

Mucolytics

Pancreatic enzyme supplements

CFTR modulators

Cystic Fibrosis (CF) Therapeutics Segment by Application

Oral drugs

Inhaled drugs

Cystic Fibrosis (CF) Therapeutics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cystic Fibrosis (CF) Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cystic Fibrosis (CF) Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cystic Fibrosis (CF) Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Cystic Fibrosis (CF) Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cystic Fibrosis (CF) Therapeutics industry.

Chapter 3: Detailed analysis of Cystic Fibrosis (CF) Therapeutics companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cystic Fibrosis (CF) Therapeuticsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Bronchodilators Table 3. Key Players of Mucolytics Table 4. Key Players of Pancreatic enzyme supplements Table 3. Key Players of CFTR modulators Table 4. Global Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Oral drugs Table 6. Key Players of Inhaled drugs Table 7. Global Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Cystic Fibrosis (CF) Therapeutics Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Cystic Fibrosis (CF) Therapeutics Market Share by Region (2021-2026) Table 10. Global Cystic Fibrosis (CF) Therapeutics Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Cystic Fibrosis (CF) Therapeutics Market Share by Region (2027-2032) Table 12. Cystic Fibrosis (CF) Therapeutics Industry Trends Table 13. Cystic Fibrosis (CF) Therapeutics Industry Drivers Table 14. Cystic Fibrosis (CF) Therapeutics Industry Opportunities and Challenges Table 15. Cystic Fibrosis (CF) Therapeutics Industry Restraints Table 16. Global Cystic Fibrosis (CF) Therapeutics Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Company (2021-2026) Table 18. Global Cystic Fibrosis (CF) Therapeutics Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Cystic Fibrosis (CF) Therapeutics Key Company Head Office and Area Served Table 20. Global Cystic Fibrosis (CF) Therapeutics Company, Product Type & Application Table 21. Global Cystic Fibrosis (CF) Therapeutics Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Cystic Fibrosis (CF) Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Cystic Fibrosis (CF) Therapeutics Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Cystic Fibrosis (CF) Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Cystic Fibrosis (CF) Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Type (2021-2026) Table 28. Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Type (2027-2032) Table 29. Global Cystic Fibrosis (CF) Therapeutics Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Cystic Fibrosis (CF) Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Cystic Fibrosis (CF) Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Application (2021-2026) Table 33. Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Application (2027-2032) Table 34. Teva Pharmaceutical Industries Ltd Company Information Table 35. Teva Pharmaceutical Industries Ltd Business Overview Table 36. Teva Pharmaceutical Industries Ltd Cystic Fibrosis (CF) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Teva Pharmaceutical Industries Ltd Cystic Fibrosis (CF) Therapeutics Product Portfolio Table 38. Teva Pharmaceutical Industries Ltd Recent Development Table 39. Novartis AG Company Information Table 40. Novartis AG Business Overview Table 41. Novartis AG Cystic Fibrosis (CF) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Novartis AG Cystic Fibrosis (CF) Therapeutics Product Portfolio Table 43. Novartis AG Recent Development Table 44. Merck & Co. Company Information Table 45. Merck & Co. Business Overview Table 46. Merck & Co. Cystic Fibrosis (CF) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Merck & Co. Cystic Fibrosis (CF) Therapeutics Product Portfolio Table 48. Merck & Co. Recent Development Table 49. Gilead Company Information Table 50. Gilead Business Overview Table 51. Gilead Cystic Fibrosis (CF) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Gilead Cystic Fibrosis (CF) Therapeutics Product Portfolio Table 53. Gilead Recent Development Table 54. AbbVie, Company Information Table 55. AbbVie, Business Overview Table 56. AbbVie, Cystic Fibrosis (CF) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. AbbVie, Cystic Fibrosis (CF) Therapeutics Product Portfolio Table 58. AbbVie, Recent Development Table 59. AstraZeneca Company Information Table 60. AstraZeneca Business Overview Table 61. AstraZeneca Cystic Fibrosis (CF) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. AstraZeneca Cystic Fibrosis (CF) Therapeutics Product Portfolio Table 63. AstraZeneca Recent Development Table 64. Vertex Pharmaceuticalsorporated Company Information Table 65. Vertex Pharmaceuticalsorporated Business Overview Table 66. Vertex Pharmaceuticalsorporated Cystic Fibrosis (CF) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Vertex Pharmaceuticalsorporated Cystic Fibrosis (CF) Therapeutics Product Portfolio Table 68. Vertex Pharmaceuticalsorporated Recent Development Table 69. F. Hoffmann-La Roche Ltd Company Information Table 70. F. Hoffmann-La Roche Ltd Business Overview Table 71. F. Hoffmann-La Roche Ltd Cystic Fibrosis (CF) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. F. Hoffmann-La Roche Ltd Cystic Fibrosis (CF) Therapeutics Product Portfolio Table 73. F. Hoffmann-La Roche Ltd Recent Development Table 74. ALLERGAN Company Information Table 75. ALLERGAN Business Overview Table 76. ALLERGAN Cystic Fibrosis (CF) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. ALLERGAN Cystic Fibrosis (CF) Therapeutics Product Portfolio Table 78. ALLERGAN Recent Development Table 79. Alcresta Company Information Table 80. Alcresta Business Overview Table 81. Alcresta Cystic Fibrosis (CF) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Alcresta Cystic Fibrosis (CF) Therapeutics Product Portfolio Table 83. Alcresta Recent Development Table 84. Alaxia Company Information Table 85. Alaxia Business Overview Table 86. Alaxia Cystic Fibrosis (CF) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Alaxia Cystic Fibrosis (CF) Therapeutics Product Portfolio Table 88. Alaxia Recent Development Table 89. AIT (Advanced Inhalation Therapies) Company Information Table 90. AIT (Advanced Inhalation Therapies) Business Overview Table 91. AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Product Portfolio Table 93. AIT (Advanced Inhalation Therapies) Recent Development Table 94. North America Cystic Fibrosis (CF) Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 95. North America Cystic Fibrosis (CF) Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 96. North America Cystic Fibrosis (CF) Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 97. North America Cystic Fibrosis (CF) Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 98. North America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. North America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2021-2026) Table 100. North America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2027-2032) Table 101. Europe Cystic Fibrosis (CF) Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 102. Europe Cystic Fibrosis (CF) Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 103. Europe Cystic Fibrosis (CF) Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 104. Europe Cystic Fibrosis (CF) Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 105. Europe Cystic Fibrosis (CF) Therapeutics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. Europe Cystic Fibrosis (CF) Therapeutics Market Size by Country (2021-2026) Table 107. Europe Cystic Fibrosis (CF) Therapeutics Market Size by Country (2027-2032) Table 108. China Cystic Fibrosis (CF) Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 109. China Cystic Fibrosis (CF) Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 110. China Cystic Fibrosis (CF) Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 111. China Cystic Fibrosis (CF) Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 112. Asia Cystic Fibrosis (CF) Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 113. Asia Cystic Fibrosis (CF) Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 114. Asia Cystic Fibrosis (CF) Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 115. Asia Cystic Fibrosis (CF) Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 116. Asia Cystic Fibrosis (CF) Therapeutics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. Asia Cystic Fibrosis (CF) Therapeutics Market Size by Country (2021-2026) Table 118. Asia Cystic Fibrosis (CF) Therapeutics Market Size by Country (2027-2032) Table 119. South America, Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 120. South America, Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 121. South America, Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 122. South America, Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 123. South America, Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. South America, Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Country (2021-2026) Table 125. South America, Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Country (2027-2032) Table 126. Research Programs/Design for This Report Table 127. Authors List of This Report Table 128. Secondary Sources Table 129. Primary Sources List of Figures Figure 1. Cystic Fibrosis (CF) Therapeutics Product Image Figure 2. Global Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Cystic Fibrosis (CF) Therapeutics Market Share by Type: 2025 VS 2032 Figure 4. Bronchodilators Image Figure 5. Mucolytics Image Figure 6. Pancreatic enzyme supplements Image Figure 7. CFTR modulators Image Figure 8. Global Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Cystic Fibrosis (CF) Therapeutics Market Share by Application: 2025 VS 2032 Figure 10. Oral drugs Image Figure 11. Inhaled drugs Image Figure 12. Global Cystic Fibrosis (CF) Therapeutics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Cystic Fibrosis (CF) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 14. Global Cystic Fibrosis (CF) Therapeutics Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Cystic Fibrosis (CF) Therapeutics Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Cystic Fibrosis (CF) Therapeutics Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Cystic Fibrosis (CF) Therapeutics Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Type (2021-2032) Figure 21. Global Cystic Fibrosis (CF) Therapeutics Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Application (2021-2032) Figure 23. North America Cystic Fibrosis (CF) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 24. North America Cystic Fibrosis (CF) Therapeutics Market Share by Type (2021-2032) Figure 25. North America Cystic Fibrosis (CF) Therapeutics Market Share by Application (2021-2032) Figure 26. North America Cystic Fibrosis (CF) Therapeutics Market Share by Country (2021-2032) Figure 27. United States Cystic Fibrosis (CF) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 28. Canada Cystic Fibrosis (CF) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Cystic Fibrosis (CF) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 30. Europe Cystic Fibrosis (CF) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 31. Europe Cystic Fibrosis (CF) Therapeutics Market Share by Type (2021-2032) Figure 32. Europe Cystic Fibrosis (CF) Therapeutics Market Share by Application (2021-2032) Figure 33. Europe Cystic Fibrosis (CF) Therapeutics Market Share by Country (2021-2032) Figure 34. Germany Cystic Fibrosis (CF) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 35. France Cystic Fibrosis (CF) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Cystic Fibrosis (CF) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 37. Italy Cystic Fibrosis (CF) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 38. Russia Cystic Fibrosis (CF) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Cystic Fibrosis (CF) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 40. China Cystic Fibrosis (CF) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 41. China Cystic Fibrosis (CF) Therapeutics Market Share by Type (2021-2032) Figure 42. China Cystic Fibrosis (CF) Therapeutics Market Share by Application (2021-2032) Figure 43. Asia Cystic Fibrosis (CF) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 44. Asia Cystic Fibrosis (CF) Therapeutics Market Share by Type (2021-2032) Figure 45. Asia Cystic Fibrosis (CF) Therapeutics Market Share by Application (2021-2032) Figure 46. Asia Cystic Fibrosis (CF) Therapeutics Market Share by Country (2021-2032) Figure 47. Japan Cystic Fibrosis (CF) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Cystic Fibrosis (CF) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Cystic Fibrosis (CF) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Cystic Fibrosis (CF) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 51. India Cystic Fibrosis (CF) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 52. Australia Cystic Fibrosis (CF) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Share by Country (2021-2032) Figure 57. Brazil Cystic Fibrosis (CF) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Cystic Fibrosis (CF) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Cystic Fibrosis (CF) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Cystic Fibrosis (CF) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Cystic Fibrosis (CF) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 62. UAE Cystic Fibrosis (CF) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Cystic Fibrosis (CF) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 64. Chile Cystic Fibrosis (CF) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Bronchodilators
  • Mucolytics
  • Pancreatic enzyme supplements
  • CFTR modulators
Applications
  • Oral drugs
  • Inhaled drugs
Companies covered
  • Teva Pharmaceutical Industries Ltd
  • Novartis AG
  • Merck & Co.
  • Gilead
  • AbbVie,
  • AstraZeneca
  • Vertex Pharmaceuticalsorporated
  • F. Hoffmann-La Roche Ltd
  • ALLERGAN
  • Alcresta
  • Alaxia
  • AIT (Advanced Inhalation Therapies)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Bronchodilators
  5. 1.2.3 Mucolytics
  6. 1.2.4 Pancreatic enzyme supplements
  7. 1.2.5 CFTR modulators
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Oral drugs
  11. 1.3.3 Inhaled drugs
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Cystic Fibrosis (CF) Therapeutics Growth Trends by Region
  14. 1.5.1 Global Cystic Fibrosis (CF) Therapeutics Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Cystic Fibrosis (CF) Therapeutics Market Size by Region (2021-2026)
  16. 1.5.3 Cystic Fibrosis (CF) Therapeutics Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Cystic Fibrosis (CF) Therapeutics Market Dynamics
  1. 2.1 Cystic Fibrosis (CF) Therapeutics Industry Trends
  2. 2.2 Cystic Fibrosis (CF) Therapeutics Industry Drivers
  3. 2.3 Cystic Fibrosis (CF) Therapeutics Industry Opportunities and Challenges
  4. 2.4 Cystic Fibrosis (CF) Therapeutics Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Cystic Fibrosis (CF) Therapeutics Revenue by Company (2021-2026)
  2. 3.2 Global Cystic Fibrosis (CF) Therapeutics Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Cystic Fibrosis (CF) Therapeutics Key Company Head office and Area Served
  4. 3.4 Global Cystic Fibrosis (CF) Therapeutics Company, Product Type & Application
  5. 3.5 Global Cystic Fibrosis (CF) Therapeutics Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Cystic Fibrosis (CF) Therapeutics Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Cystic Fibrosis (CF) Therapeutics Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Cystic Fibrosis (CF) Therapeutics Tier 1, Tier 2, and Tier 3
4 Cystic Fibrosis (CF) Therapeutics Market by Type
  1. 4.1 Global Cystic Fibrosis (CF) Therapeutics Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Cystic Fibrosis (CF) Therapeutics Market Size by Type (2021-2032)
  3. 4.3 Global Cystic Fibrosis (CF) Therapeutics Market Size Share by Type (2021-2032)
5 Cystic Fibrosis (CF) Therapeutics Market by Application
  1. 5.1 Global Cystic Fibrosis (CF) Therapeutics Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Cystic Fibrosis (CF) Therapeutics Market Size by Application (2021-2032)
  3. 5.3 Global Cystic Fibrosis (CF) Therapeutics Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Teva Pharmaceutical Industries Ltd
  2. 6.1.1 Teva Pharmaceutical Industries Ltd Company Information
  3. 6.1.2 Teva Pharmaceutical Industries Ltd Business Overview
  4. 6.1.3 Teva Pharmaceutical Industries Ltd Cystic Fibrosis (CF) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Teva Pharmaceutical Industries Ltd Cystic Fibrosis (CF) Therapeutics Product Portfolio
  6. 6.1.5 Teva Pharmaceutical Industries Ltd Recent Developments
  7. 6.2 Novartis AG
  8. 6.2.1 Novartis AG Company Information
  9. 6.2.2 Novartis AG Business Overview
  10. 6.2.3 Novartis AG Cystic Fibrosis (CF) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Novartis AG Cystic Fibrosis (CF) Therapeutics Product Portfolio
  12. 6.2.5 Novartis AG Recent Developments
  13. 6.3 Merck & Co.
  14. 6.3.1 Merck & Co. Company Information
  15. 6.3.2 Merck & Co. Business Overview
  16. 6.3.3 Merck & Co. Cystic Fibrosis (CF) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Merck & Co. Cystic Fibrosis (CF) Therapeutics Product Portfolio
  18. 6.3.5 Merck & Co. Recent Developments
  19. 6.4 Gilead
  20. 6.4.1 Gilead Company Information
  21. 6.4.2 Gilead Business Overview
  22. 6.4.3 Gilead Cystic Fibrosis (CF) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Gilead Cystic Fibrosis (CF) Therapeutics Product Portfolio
  24. 6.4.5 Gilead Recent Developments
  25. 6.5 AbbVie,
  26. 6.5.1 AbbVie, Company Information
  27. 6.5.2 AbbVie, Business Overview
  28. 6.5.3 AbbVie, Cystic Fibrosis (CF) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 AbbVie, Cystic Fibrosis (CF) Therapeutics Product Portfolio
  30. 6.5.5 AbbVie, Recent Developments
  31. 6.6 AstraZeneca
  32. 6.6.1 AstraZeneca Company Information
  33. 6.6.2 AstraZeneca Business Overview
  34. 6.6.3 AstraZeneca Cystic Fibrosis (CF) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 AstraZeneca Cystic Fibrosis (CF) Therapeutics Product Portfolio
  36. 6.6.5 AstraZeneca Recent Developments
  37. 6.7 Vertex Pharmaceuticalsorporated
  38. 6.7.1 Vertex Pharmaceuticalsorporated Company Information
  39. 6.7.2 Vertex Pharmaceuticalsorporated Business Overview
  40. 6.7.3 Vertex Pharmaceuticalsorporated Cystic Fibrosis (CF) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Vertex Pharmaceuticalsorporated Cystic Fibrosis (CF) Therapeutics Product Portfolio
  42. 6.7.5 Vertex Pharmaceuticalsorporated Recent Developments
  43. 6.8 F. Hoffmann-La Roche Ltd
  44. 6.8.1 F. Hoffmann-La Roche Ltd Company Information
  45. 6.8.2 F. Hoffmann-La Roche Ltd Business Overview
  46. 6.8.3 F. Hoffmann-La Roche Ltd Cystic Fibrosis (CF) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 F. Hoffmann-La Roche Ltd Cystic Fibrosis (CF) Therapeutics Product Portfolio
  48. 6.8.5 F. Hoffmann-La Roche Ltd Recent Developments
  49. 6.9 ALLERGAN
  50. 6.9.1 ALLERGAN Company Information
  51. 6.9.2 ALLERGAN Business Overview
  52. 6.9.3 ALLERGAN Cystic Fibrosis (CF) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 ALLERGAN Cystic Fibrosis (CF) Therapeutics Product Portfolio
  54. 6.9.5 ALLERGAN Recent Developments
  55. 6.10 Alcresta
  56. 6.10.1 Alcresta Company Information
  57. 6.10.2 Alcresta Business Overview
  58. 6.10.3 Alcresta Cystic Fibrosis (CF) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Alcresta Cystic Fibrosis (CF) Therapeutics Product Portfolio
  60. 6.10.5 Alcresta Recent Developments
  61. 6.11 Alaxia
  62. 6.11.1 Alaxia Company Information
  63. 6.11.2 Alaxia Business Overview
  64. 6.11.3 Alaxia Cystic Fibrosis (CF) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Alaxia Cystic Fibrosis (CF) Therapeutics Product Portfolio
  66. 6.11.5 Alaxia Recent Developments
  67. 6.12 AIT (Advanced Inhalation Therapies)
  68. 6.12.1 AIT (Advanced Inhalation Therapies) Company Information
  69. 6.12.2 AIT (Advanced Inhalation Therapies) Business Overview
  70. 6.12.3 AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Product Portfolio
  72. 6.12.5 AIT (Advanced Inhalation Therapies) Recent Developments
7 North America
  1. 7.1 North America Cystic Fibrosis (CF) Therapeutics Market Size (2021-2032)
  2. 7.2 North America Cystic Fibrosis (CF) Therapeutics Market Size by Type
  3. 7.2.1 North America Cystic Fibrosis (CF) Therapeutics Market Size by Type (2021-2026)
  4. 7.2.2 North America Cystic Fibrosis (CF) Therapeutics Market Size by Type (2027-2032)
  5. 7.2.3 North America Cystic Fibrosis (CF) Therapeutics Market Share by Type (2021-2032)
  6. 7.3 North America Cystic Fibrosis (CF) Therapeutics Market Size by Application
  7. 7.3.1 North America Cystic Fibrosis (CF) Therapeutics Market Size by Application (2021-2026)
  8. 7.3.2 North America Cystic Fibrosis (CF) Therapeutics Market Size by Application (2027-2032)
  9. 7.3.3 North America Cystic Fibrosis (CF) Therapeutics Market Share by Application (2021-2032)
  10. 7.4 North America Cystic Fibrosis (CF) Therapeutics Market Size by Country
  11. 7.4.1 North America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2021-2026)
  13. 7.4.3 North America Cystic Fibrosis (CF) Therapeutics Market Size by Country (2027-2032)
  14. 7.4.4 North America Cystic Fibrosis (CF) Therapeutics Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Cystic Fibrosis (CF) Therapeutics Market Size (2021-2032)
  2. 8.2 Europe Cystic Fibrosis (CF) Therapeutics Market Size by Type
  3. 8.2.1 Europe Cystic Fibrosis (CF) Therapeutics Market Size by Type (2021-2026)
  4. 8.2.2 Europe Cystic Fibrosis (CF) Therapeutics Market Size by Type (2027-2032)
  5. 8.2.3 Europe Cystic Fibrosis (CF) Therapeutics Market Share by Type (2021-2032)
  6. 8.3 Europe Cystic Fibrosis (CF) Therapeutics Market Size by Application
  7. 8.3.1 Europe Cystic Fibrosis (CF) Therapeutics Market Size by Application (2021-2026)
  8. 8.3.2 Europe Cystic Fibrosis (CF) Therapeutics Market Size by Application (2027-2032)
  9. 8.3.3 Europe Cystic Fibrosis (CF) Therapeutics Market Share by Application (2021-2032)
  10. 8.4 Europe Cystic Fibrosis (CF) Therapeutics Market Size by Country
  11. 8.4.1 Europe Cystic Fibrosis (CF) Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Cystic Fibrosis (CF) Therapeutics Market Size by Country (2021-2026)
  13. 8.4.3 Europe Cystic Fibrosis (CF) Therapeutics Market Size by Country (2027-2032)
  14. 8.4.4 Europe Cystic Fibrosis (CF) Therapeutics Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Cystic Fibrosis (CF) Therapeutics Market Size (2021-2032)
  2. 9.2 China Cystic Fibrosis (CF) Therapeutics Market Size by Type
  3. 9.2.1 China Cystic Fibrosis (CF) Therapeutics Market Size by Type (2021-2026)
  4. 9.2.2 China Cystic Fibrosis (CF) Therapeutics Market Size by Type (2027-2032)
  5. 9.2.3 China Cystic Fibrosis (CF) Therapeutics Market Share by Type (2021-2032)
  6. 9.3 China Cystic Fibrosis (CF) Therapeutics Market Size by Application
  7. 9.3.1 China Cystic Fibrosis (CF) Therapeutics Market Size by Application (2021-2026)
  8. 9.3.2 China Cystic Fibrosis (CF) Therapeutics Market Size by Application (2027-2032)
  9. 9.3.3 China Cystic Fibrosis (CF) Therapeutics Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Cystic Fibrosis (CF) Therapeutics Market Size (2021-2032)
  2. 10.2 Asia Cystic Fibrosis (CF) Therapeutics Market Size by Type
  3. 10.2.1 Asia Cystic Fibrosis (CF) Therapeutics Market Size by Type (2021-2026)
  4. 10.2.2 Asia Cystic Fibrosis (CF) Therapeutics Market Size by Type (2027-2032)
  5. 10.2.3 Asia Cystic Fibrosis (CF) Therapeutics Market Share by Type (2021-2032)
  6. 10.3 Asia Cystic Fibrosis (CF) Therapeutics Market Size by Application
  7. 10.3.1 Asia Cystic Fibrosis (CF) Therapeutics Market Size by Application (2021-2026)
  8. 10.3.2 Asia Cystic Fibrosis (CF) Therapeutics Market Size by Application (2027-2032)
  9. 10.3.3 Asia Cystic Fibrosis (CF) Therapeutics Market Share by Application (2021-2032)
  10. 10.4 Asia Cystic Fibrosis (CF) Therapeutics Market Size by Country
  11. 10.4.1 Asia Cystic Fibrosis (CF) Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Cystic Fibrosis (CF) Therapeutics Market Size by Country (2021-2026)
  13. 10.4.3 Asia Cystic Fibrosis (CF) Therapeutics Market Size by Country (2027-2032)
  14. 10.4.4 Asia Cystic Fibrosis (CF) Therapeutics Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Cystic Fibrosis (CF) Therapeutics Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst